Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial
OBJECTIVE: To evaluate the efficacy and safety of galantamine in the treatment of Alzheimer's disease. DESIGN: Randomised, double blind, parallel group, placebo controlled trial. SETTING: 86 outpatient clinics in Europe and Canada. PARTICIPANTS: 653 patients with mild to moderate Alzheimer's disease...
Enregistré dans:
| Publié dans: | BMJ |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2000
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC27547/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11110737/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.321.7274.1445 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|